JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
State Street SPDR Dow Jones REIT ETF
RWR
$1.77B
| $3.71M | ﹤0.01% |
39,357
+6,923
| +21% | +$644K |
2013 Q2
43 quarters
|
|
3227
Zeta Global
ZETA
$8.27B
| $3.7M | ﹤0.01% |
338,858
+142,274
| +72% | +$1.42M |
2021 Q4
9 quarters
|
|
3228
Northwest Bancshares
NWBI
$2.19B
| $3.69M | ﹤0.01% |
317,056
-42,360
| -12% | -$502K |
2015 Q4
33 quarters
|
|
|
SHOE
3229
Shoe Station Group
SHOE
$354M
| $3.68M | ﹤0.01% |
100,473
-4,903
| -5% | -$145K |
2016 Q4
29 quarters
|
|
3230
PUT
PPG Industries
PPG
$23.7B
| $3.68M | ﹤0.01% |
25,400
+15,400
| +154% | +$2.19M |
2023 Q2
3 quarters
|
|
3231
VTEX
VTEX
$628M
| $3.68M | ﹤0.01% |
449,931
+21,526
| +5% | +$172K |
2023 Q2
3 quarters
|
|
3232
Oaktree Specialty Lending
OCSL
$1.03B
| $3.67M | ﹤0.01% |
186,903
-45,005
| -19% | -$909K |
2022 Q3
6 quarters
|
|
3233
Ooma
OOMA
$548M
| $3.67M | ﹤0.01% |
430,564
+98,195
| +30% | +$977K |
2017 Q3
26 quarters
|
|
3234
Keros Therapeutics
KROS
$218M
| $3.67M | ﹤0.01% |
55,410
-7,234
| -12% | -$429K |
2020 Q2
15 quarters
|
|
3235
WisdomTree US LargeCap Fund
EPS
$1.68B
| $3.66M | ﹤0.01% |
66,128
-51,088
| -44% | -$2.68M |
2022 Q1
8 quarters
|
|
3236
CALL
Vale
VALE
$59.9B
| $3.66M | ﹤0.01% |
300,000
+214,500
| +251% | +$2.9M |
2021 Q4
9 quarters
|
|
3237
Mirum Pharmaceuticals
MIRM
$5.15B
| $3.66M | ﹤0.01% |
145,560
-41,023
| -22% | -$1.13M |
2019 Q3
18 quarters
|
|
3238
Ligand Pharmaceuticals
LGND
$5.92B
| $3.66M | ﹤0.01% |
50,006
-12,873
| -20% | -$949K |
2015 Q4
33 quarters
|
|
3239
PUT
Baker Hughes
BKR
$56.7B
| $3.65M | ﹤0.01% |
109,100
+80,300
| +279% | +$2.48M |
2023 Q3
2 quarters
|
|
|
IAS
3240
DELISTED
Integral Ad Science
IAS
| $3.65M | ﹤0.01% |
366,574
+88,634
| +32% | +$1.18M |
2021 Q2
11 quarters
|
|
3241
PUT
Synchrony
SYF
$23.5B
| $3.65M | ﹤0.01% |
84,700
-34,400
| -29% | -$1.37M |
2023 Q3
2 quarters
|
|
|
PTVE
3242
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $3.64M | ﹤0.01% |
254,483
+87,100
| +52% | +$1.23M |
2020 Q3
14 quarters
|
|
3243
Smith & Wesson
SWBI
$651M
| $3.64M | ﹤0.01% |
209,781
+71,021
| +51% | +$1.02M |
2015 Q4
33 quarters
|
|
3244
Safe Bulkers
SB
$977M
| $3.63M | ﹤0.01% |
731,361
+6,163
| +0.8% | +$27.1K |
2017 Q4
25 quarters
|
|
|
3245
CALL
PPG Industries
PPG
$23.7B
| $3.62M | ﹤0.01% |
25,000
+15,000
| +150% | +$2.13M |
2023 Q2
3 quarters
|
|
3246
Procept Biorobotics
PRCT
$1B
| $3.62M | ﹤0.01% |
73,189
-47,058
| -39% | -$2.24M |
2021 Q4
9 quarters
|
|
3247
Resources Connection
RGP
$127M
| $3.61M | ﹤0.01% |
274,133
+41,413
| +18% | +$553K |
2013 Q2
43 quarters
|
|
3248
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
MFUS
$303M
| $3.61M | ﹤0.01% |
76,461
+24,738
| +48% | +$1.09M |
2022 Q4
5 quarters
|
|
3249
Kodiak Gas Services
KGS
$5.65B
| $3.6M | ﹤0.01% |
131,704
+71,105
| +117% | +$1.71M |
2023 Q3
2 quarters
|
|
3250
Weis Markets
WMK
$1.8B
| $3.6M | ﹤0.01% |
55,827
-16,433
| -23% | -$1.03M |
2015 Q4
33 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.